Casdin Capital, LLC Syros Pharmaceuticals, Inc. Transaction History

Casdin Capital, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 15, 2018	SELL	$9.47 - $12.98 $2.6 Million - $3.56 Million	-274,074 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.45 - $17.48 $150,908 - $312,175	17,859 Added 6.97%	274,074 $2.67 Million
Q3 2017 Nov 14, 2017	BUY	$13.52 - $23.75 $3.46 Million - $6.09 Million	256,215	256,215 $3.77 Million

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.